vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and PDF SOLUTIONS INC (PDFS). Click either name above to swap in a different company.

PDF SOLUTIONS INC is the larger business by last-quarter revenue ($62.4M vs $45.1M, roughly 1.4× Amarin Corp plc). PDF SOLUTIONS INC runs the higher net margin — -0.1% vs -23.3%, a 23.2% gap on every dollar of revenue. On growth, PDF SOLUTIONS INC posted the faster year-over-year revenue change (24.6% vs 7.0%). Over the past eight quarters, PDF SOLUTIONS INC's revenue compounded faster (22.9% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

PDF Solutions, Inc. is an American multinational software and engineering services company based in Santa Clara, California. The company is listed in the Nasdaq stock exchange under the ticker symbol PDFS.

AMRN vs PDFS — Head-to-Head

Bigger by revenue
PDFS
PDFS
1.4× larger
PDFS
$62.4M
$45.1M
AMRN
Growing faster (revenue YoY)
PDFS
PDFS
+17.6% gap
PDFS
24.6%
7.0%
AMRN
Higher net margin
PDFS
PDFS
23.2% more per $
PDFS
-0.1%
-23.3%
AMRN
Faster 2-yr revenue CAGR
PDFS
PDFS
Annualised
PDFS
22.9%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
PDFS
PDFS
Revenue
$45.1M
$62.4M
Net Profit
$-10.5M
$-48.0K
Gross Margin
72.9%
Operating Margin
35.5%
5.5%
Net Margin
-23.3%
-0.1%
Revenue YoY
7.0%
24.6%
Net Profit YoY
33.0%
-108.9%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
PDFS
PDFS
Q1 26
$45.1M
Q4 25
$49.2M
$62.4M
Q3 25
$49.7M
$57.1M
Q2 25
$72.7M
$51.7M
Q1 25
$42.0M
$47.8M
Q4 24
$62.3M
$50.1M
Q3 24
$42.3M
$46.4M
Q2 24
$67.5M
$41.7M
Net Profit
AMRN
AMRN
PDFS
PDFS
Q1 26
$-10.5M
Q4 25
$-1.2M
$-48.0K
Q3 25
$-7.7M
$1.3M
Q2 25
$-14.1M
$1.1M
Q1 25
$-15.7M
$-3.0M
Q4 24
$-48.6M
$539.0K
Q3 24
$-25.1M
$2.2M
Q2 24
$1.5M
$1.7M
Gross Margin
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
47.1%
72.9%
Q3 25
44.7%
72.3%
Q2 25
69.2%
71.2%
Q1 25
59.8%
72.9%
Q4 24
-15.4%
68.3%
Q3 24
38.5%
73.1%
Q2 24
63.4%
70.6%
Operating Margin
AMRN
AMRN
PDFS
PDFS
Q1 26
35.5%
Q4 25
-12.9%
5.5%
Q3 25
-22.4%
8.5%
Q2 25
-22.0%
2.2%
Q1 25
-39.9%
-7.4%
Q4 24
-84.3%
1.0%
Q3 24
-59.5%
4.6%
Q2 24
-0.8%
0.6%
Net Margin
AMRN
AMRN
PDFS
PDFS
Q1 26
-23.3%
Q4 25
-2.5%
-0.1%
Q3 25
-15.6%
2.3%
Q2 25
-19.4%
2.2%
Q1 25
-37.4%
-6.3%
Q4 24
-78.0%
1.1%
Q3 24
-59.4%
4.8%
Q2 24
2.3%
4.1%
EPS (diluted)
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
$0.00
$0.00
Q3 25
$-0.02
$0.03
Q2 25
$-0.03
$0.03
Q1 25
$-0.04
$-0.08
Q4 24
$-0.12
$0.01
Q3 24
$-0.06
$0.06
Q2 24
$0.00
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
PDFS
PDFS
Cash + ST InvestmentsLiquidity on hand
$307.8M
$42.2M
Total DebtLower is stronger
$67.0M
Stockholders' EquityBook value
$271.0M
Total Assets
$645.8M
$418.7M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
PDFS
PDFS
Q1 26
$307.8M
Q4 25
$302.6M
$42.2M
Q3 25
$286.6M
$35.9M
Q2 25
$298.7M
$40.4M
Q1 25
$281.8M
$54.1M
Q4 24
$294.2M
$114.9M
Q3 24
$305.7M
$120.2M
Q2 24
$306.7M
$117.9M
Total Debt
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
$67.0M
Q3 25
$67.6M
Q2 25
$68.1M
Q1 25
$68.7M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
$459.3M
$271.0M
Q3 25
$458.9M
$264.4M
Q2 25
$464.9M
$257.5M
Q1 25
$473.7M
$249.0M
Q4 24
$486.2M
$246.0M
Q3 24
$531.4M
$240.5M
Q2 24
$551.9M
$232.2M
Total Assets
AMRN
AMRN
PDFS
PDFS
Q1 26
$645.8M
Q4 25
$670.8M
$418.7M
Q3 25
$659.8M
$406.4M
Q2 25
$670.1M
$391.1M
Q1 25
$655.7M
$390.0M
Q4 24
$685.3M
$315.3M
Q3 24
$750.6M
$307.4M
Q2 24
$799.9M
$298.0M
Debt / Equity
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
0.25×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.28×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
PDFS
PDFS
Operating Cash FlowLast quarter
$17.3M
Free Cash FlowOCF − Capex
$7.5M
FCF MarginFCF / Revenue
12.1%
Capex IntensityCapex / Revenue
15.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
$15.3M
$17.3M
Q3 25
$-12.7M
$3.3M
Q2 25
$16.6M
$-5.2M
Q1 25
$-12.5M
$8.6M
Q4 24
$-13.3M
$1.6M
Q3 24
$-2.4M
$9.3M
Q2 24
$-2.7M
$684.0K
Free Cash Flow
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
$7.5M
Q3 25
$-2.9M
Q2 25
$-13.8M
Q1 25
$535.0K
Q4 24
$-4.0M
Q3 24
$5.1M
Q2 24
$-4.6M
FCF Margin
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
12.1%
Q3 25
-5.1%
Q2 25
-26.6%
Q1 25
1.1%
Q4 24
-8.0%
Q3 24
11.0%
Q2 24
-11.1%
Capex Intensity
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
15.7%
Q3 25
10.8%
Q2 25
16.5%
Q1 25
17.0%
Q4 24
11.3%
Q3 24
9.0%
Q2 24
12.8%
Cash Conversion
AMRN
AMRN
PDFS
PDFS
Q1 26
Q4 25
Q3 25
2.54×
Q2 25
-4.55×
Q1 25
Q4 24
2.98×
Q3 24
4.20×
Q2 24
-1.81×
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

PDFS
PDFS

Volumebased$38.0M61%
Other$24.4M39%

Related Comparisons